Wai Yuen Tong Medicine Holdings Limited (Stock Code: 897) disclosed an expected decrease in the profit attributable to owners of the parent for the six months ended 30 September 2025. Based on preliminary unaudited consolidated management accounts, the figure is projected to drop from approximately HK$23.7 million last year to not more than HK$3.0 million.

A weakened retail market contributed to a roughly 7% decline in revenue and a corresponding reduction in gross profit. Additionally, net gains on property disposals and net fair value gains on investment properties decreased substantially. These impacts were partially offset by reduced administrative expenses and finance costs.

The final interim results will be released by the end of November 2025, as required by the Listing Rules. Shareholders and investors are advised to exercise caution in share transactions.